Fintech

GlycoNex Inc. and Nippon Kayaku Co., Ltd. Enter Collaboration to Advance Next-Generation ADC Candidate GNX201-ADC

Prnewswire·March 23, 2026 at 12:34 PM

/PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical-stage biotechnology company focused on the development of glycan-directed...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

Middle Market Firms Limit Crypto Use
PYMNTS
Kalshi Tech Blocks Insider Trading on Prediction Markets
PYMNTS
Stablecoin yield rules restrictive in crypto bill
CoinDesk
RBC targets $1 billion from AI integration
PYMNTS

GlycoNex Inc. and Nippon Kayaku Co., Ltd. Enter Collaboration to Advance Next-Generation ADC Candidate GNX201-ADC

Middle Market Firms Limit Crypto Use

Kalshi Tech Blocks Insider Trading on Prediction Markets

Stablecoin yield rules restrictive in crypto bill

RBC targets $1 billion from AI integration